1. Home
  2. ANGO vs HBCP Comparison

ANGO vs HBCP Comparison

Compare ANGO & HBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANGO
  • HBCP
  • Stock Information
  • Founded
  • ANGO 1988
  • HBCP 1908
  • Country
  • ANGO United States
  • HBCP United States
  • Employees
  • ANGO N/A
  • HBCP N/A
  • Industry
  • ANGO Medical/Dental Instruments
  • HBCP Banks
  • Sector
  • ANGO Health Care
  • HBCP Finance
  • Exchange
  • ANGO Nasdaq
  • HBCP Nasdaq
  • Market Cap
  • ANGO 400.8M
  • HBCP 425.1M
  • IPO Year
  • ANGO 2004
  • HBCP 2008
  • Fundamental
  • Price
  • ANGO $11.05
  • HBCP $52.07
  • Analyst Decision
  • ANGO Strong Buy
  • HBCP Buy
  • Analyst Count
  • ANGO 3
  • HBCP 3
  • Target Price
  • ANGO $19.33
  • HBCP $59.00
  • AVG Volume (30 Days)
  • ANGO 587.8K
  • HBCP 28.4K
  • Earning Date
  • ANGO 10-02-2025
  • HBCP 10-20-2025
  • Dividend Yield
  • ANGO N/A
  • HBCP 2.24%
  • EPS Growth
  • ANGO N/A
  • HBCP 14.51
  • EPS
  • ANGO N/A
  • HBCP 5.21
  • Revenue
  • ANGO $300,718,000.00
  • HBCP $140,948,000.00
  • Revenue This Year
  • ANGO $7.42
  • HBCP $1.95
  • Revenue Next Year
  • ANGO $6.36
  • HBCP $3.95
  • P/E Ratio
  • ANGO N/A
  • HBCP $9.96
  • Revenue Growth
  • ANGO 2.73
  • HBCP 8.55
  • 52 Week Low
  • ANGO $5.99
  • HBCP $39.59
  • 52 Week High
  • ANGO $13.50
  • HBCP $61.07
  • Technical
  • Relative Strength Index (RSI)
  • ANGO 55.56
  • HBCP 35.86
  • Support Level
  • ANGO $10.78
  • HBCP $54.44
  • Resistance Level
  • ANGO $12.76
  • HBCP $56.24
  • Average True Range (ATR)
  • ANGO 0.52
  • HBCP 1.27
  • MACD
  • ANGO -0.05
  • HBCP -0.38
  • Stochastic Oscillator
  • ANGO 27.12
  • HBCP 2.46

About ANGO AngioDynamics Inc.

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

About HBCP Home Bancorp Inc.

Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.

Share on Social Networks: